US EditionMedical supplies firm Medline raises about $6.3 billion in 2025's biggest IPO
Medline raised $6.26 billion by selling 216 million shares at $29 each to reduce debt and create shareholder value after decades of family ownership and private equity takeover.
- Wednesday, Medline priced its IPO, selling about 216 million shares at $29 and raising $6.26 billion before beginning trading on Nasdaq Global Select Market as MDLN.
- The Mills family sold a majority stake in 2021 to Blackstone Group, Carlyle Group and Hellman & Friedman after a $34 billion deal, with plans to sell 216 million shares earlier this month.
- Medline's product range and debt profile underpin its financial picture, with over 43,000 employees worldwide, $20.6 billion in nine-month sales, and around $16.8 billion in total debt as of late September 2025.
- The upsized deal rounds out a strong year for U.S. listings as Medline raises $6.26 billion to reduce debt, remaining highly leveraged, and marks the largest U.S. IPO since Rivian's $13.7 billion listing.
- Facing tariff exposure, Medline estimates $325 million to $375 million hits in 2025 and $150 million to $200 million in 2026; most products come from Asian manufacturing and China, with competition from McKesson and Cardinal Health.
28 Articles
28 Articles
Medline (MDLN) Stock Falls In After-Hours Trading Following 41% IPO Surge - Barclays (NYSE:BCS), Citigroup (NYSE:C)
Medline Inc. (NASDAQ:MDLN) shares are trending on Thursday. Check out the current price of MDLN stock here. Shares of the healthcare company surged 41.38% in regular trading hours on Wednesday, tapering off to a 2.47% decline at $39.99 in after-hours trading. Medline priced its upsized initial public offering at $29 per share for 216.03 million Class A common shares, the company announced on Tuesday. Big news! Medline is officially trading on t…
Medline Surges After Year’s Most Valuable IPO
If 21st-century markets were an episode of The Andy Griffith Show, this news might have cued Gomer Pyle’s trademark line, “Surprise, surprise, surprise.” The biggest IPO of 2025 has no connection to artificial intelligence, semiconductors or data centers. It’s for a company that makes hospital gowns. On Wednesday, shares of medical supply company Medline jumped 40% in their Nasdaq debut, closing at $40 a pop after being priced at $29 in an IPO v…
Medline rises in Nasdaq debut, tops 2025 IPOs with $46B valuation | Honolulu Star-Advertiser
Medline shares rose 20.7% in their hotly anticipated New York debut today, valuing the medical supply giant at $46 billion in the largest U.S. initial public offering since Rivian’s 2021 listing, capping a strong year for new listings and fueling optimism for 2026.
Coverage Details
Bias Distribution
- 67% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
